176 related articles for article (PubMed ID: 24887303)
1. Differential effects of omeprazole and lansoprazole enantiomers on aryl hydrocarbon receptor in human hepatocytes and cell lines.
Novotna A; Srovnalova A; Svecarova M; Korhonova M; Bartonkova I; Dvorak Z
PLoS One; 2014; 9(6):e98711. PubMed ID: 24887303
[TBL] [Abstract][Full Text] [Related]
2. Omeprazole and lansoprazole enantiomers induce CYP3A4 in human hepatocytes and cell lines via glucocorticoid receptor and pregnane X receptor axis.
Novotna A; Dvorak Z
PLoS One; 2014; 9(8):e105580. PubMed ID: 25141173
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective disposition of proton pump inhibitors.
Andersson T; Weidolf L
Clin Drug Investig; 2008; 28(5):263-79. PubMed ID: 18407713
[TBL] [Abstract][Full Text] [Related]
4. Enantiospecific effects of ketoconazole on aryl hydrocarbon receptor.
Novotna A; Korhonova M; Bartonkova I; Soshilov AA; Denison MS; Bogdanova K; Kolar M; Bednar P; Dvorak Z
PLoS One; 2014; 9(7):e101832. PubMed ID: 25000292
[TBL] [Abstract][Full Text] [Related]
5. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
Curi-Pedrosa R; Daujat M; Pichard L; Ourlin JC; Clair P; Gervot L; Lesca P; Domergue J; Joyeux H; Fourtanier G
J Pharmacol Exp Ther; 1994 Apr; 269(1):384-92. PubMed ID: 8169844
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19.
Zvyaga T; Chang SY; Chen C; Yang Z; Vuppugalla R; Hurley J; Thorndike D; Wagner A; Chimalakonda A; Rodrigues AD
Drug Metab Dispos; 2012 Sep; 40(9):1698-711. PubMed ID: 22648560
[TBL] [Abstract][Full Text] [Related]
7. The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel.
Ogilvie BW; Yerino P; Kazmi F; Buckley DB; Rostami-Hodjegan A; Paris BL; Toren P; Parkinson A
Drug Metab Dispos; 2011 Nov; 39(11):2020-33. PubMed ID: 21795468
[TBL] [Abstract][Full Text] [Related]
8. Omeprazole induces NAD(P)H quinone oxidoreductase 1 via aryl hydrocarbon receptor-independent mechanisms: Role of the transcription factor nuclear factor erythroid 2-related factor 2.
Zhang S; Patel A; Moorthy B; Shivanna B
Biochem Biophys Res Commun; 2015 Nov; 467(2):282-7. PubMed ID: 26441083
[TBL] [Abstract][Full Text] [Related]
9. Mono-methylindoles induce CYP1A genes and inhibit CYP1A1 enzyme activity in human hepatocytes and HepaRG cells.
Vyhlídalová B; Poulíková K; Bartoňková I; Krasulová K; Vančo J; Trávníček Z; Mani S; Dvořák Z
Toxicol Lett; 2019 Oct; 313():66-76. PubMed ID: 31201936
[TBL] [Abstract][Full Text] [Related]
10. Itraconazole cis-diastereoisomers activate aryl hydrocarbon receptor AhR and pregnane X receptor PXR and induce CYP1A1 in human cell lines and human hepatocytes.
Stepankova M; Pastorkova B; Bachleda P; Dvorak Z
Toxicology; 2017 May; 383():40-49. PubMed ID: 28390928
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Antioxidant Effects of the Proton Pump-Inhibiting Drugs Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Rabeprazole.
Abed MN; Alassaf FA; Jasim MHM; Alfahad M; Qazzaz ME
Pharmacology; 2020; 105(11-12):645-651. PubMed ID: 32289807
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of the CYP1A induction potential of pantoprazole in primary rat hepatocytes: a comparison with other proton pump inhibitors.
Masubuchi N; Okazaki O
Chem Biol Interact; 1997 Nov; 107(1-2):63-74. PubMed ID: 9402950
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective inhibition of cytochrome P450 forms by lansoprazole and omeprazole in vitro.
Liu KH; Kim MJ; Shon JH; Moon YS; Seol SY; Kang W; Cha IJ; Shin JG
Xenobiotica; 2005 Jan; 35(1):27-38. PubMed ID: 15788366
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypes.
Miura M; Tada H; Yasui-Furukori N; Uno T; Sugawara K; Tateishi T; Suzuki T
Eur J Clin Pharmacol; 2004 Nov; 60(9):623-8. PubMed ID: 15448955
[TBL] [Abstract][Full Text] [Related]
15. Twice-daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice-daily omeprazole, rabeprazole or lansoprazole.
Sahara S; Sugimoto M; Uotani T; Ichikawa H; Yamade M; Iwaizumi M; Yamada T; Osawa S; Sugimoto K; Umemura K; Miyajima H; Furuta T
Aliment Pharmacol Ther; 2013 Nov; 38(9):1129-37. PubMed ID: 24099474
[TBL] [Abstract][Full Text] [Related]
16. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
Li XQ; Andersson TB; Ahlström M; Weidolf L
Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
[TBL] [Abstract][Full Text] [Related]
17. Role of CYP3A4 in the regulation of the aryl hydrocarbon receptor by omeprazole sulphide.
Gerbal-Chaloin S; Pichard-Garcia L; Fabre JM; Sa-Cunha A; Poellinger L; Maurel P; Daujat-Chavanieu M
Cell Signal; 2006 May; 18(5):740-50. PubMed ID: 16109480
[TBL] [Abstract][Full Text] [Related]
18. Induction of CYP1A1 gene by benzimidazole derivatives during Caco-2 cell differentiation. Evidence for an aryl-hydrocarbon receptor-mediated mechanism.
Daujat M; Charrasse S; Fabre I; Lesca P; Jounaïdi Y; Larroque C; Poellinger L; Maurel P
Eur J Biochem; 1996 May; 237(3):642-52. PubMed ID: 8647108
[TBL] [Abstract][Full Text] [Related]
19. Hydroxystilbenes and methoxystilbenes activate human aryl hydrocarbon receptor and induce CYP1A genes in human hepatoma cells and human hepatocytes.
Pastorková B; Vrzalová A; Bachleda P; Dvořák Z
Food Chem Toxicol; 2017 May; 103():122-132. PubMed ID: 28279696
[TBL] [Abstract][Full Text] [Related]
20. Identification of amino acid residues in the ligand-binding domain of the aryl hydrocarbon receptor causing the species-specific response to omeprazole: possible determinants for binding putative endogenous ligands.
Shiizaki K; Ohsako S; Kawanishi M; Yagi T
Mol Pharmacol; 2014 Feb; 85(2):279-89. PubMed ID: 24265133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
